The FDA endorses accelerated approval reforms

The FDA is asking Congress for more authority to crack down on drug makers abusing the so-called accelerated approval pathway.

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

The NIH’s long Covid research is a mess

Read the rest…